Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Early P 1 (1)

Trial Status

Completed1
Recruiting1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05023889Early Phase 1Active Not Recruiting

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

NCT06291805Recruiting

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

NCT04276220Not ApplicableCompleted

Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery

Showing all 3 trials

Research Network

Activity Timeline